Harmony Biosciences Holdings (HRMY) EPS (Basic) (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported EPS (Basic) of $0.56 for Q1 2026, down 29.32% on a YoY basis from $0.79 in Q1 2025, and down 50.5% sequentially from $1.14 in Q4 2025.
Harmony Biosciences Holdings (HRMY) EPS (Basic) (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of EPS (Basic) data on file, last reported at $0.56 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 29.32% year-over-year to $0.56; the trailing twelve-month figure through Mar 2026 stood at $3.26 (up 22.27% YoY), and the FY2025 full-year result was $3.5, up 37.01% from the prior year.
- EPS (Basic) eased to $0.56 in Q1 2026, from $1.14 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.48 in Q3 2022 to a low of $0.2 in Q2 2024.
- A 5-year average of $0.7 and a median of $0.68 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 990.83% in 2022 and slumped 64.32% in 2024, its largest moves.
- Tracing HRMY's EPS (Basic) over 5 years: stood at $0.82 in 2022, then tumbled by 45.42% to $0.45 in 2023, then surged by 94.39% to $0.87 in 2024, then soared by 30.52% to $1.14 in 2025, then sank by 50.5% to $0.56 in 2026.
- Business Quant data shows HRMY's EPS (Basic) at $0.56 in Q1 2026, $1.14 in Q4 2025, and $0.88 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | 1.14 |
| Sep 30, 2025 | 0.88 |
| Jun 30, 2025 | 0.69 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.81 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.68 |
| Dec 31, 2023 | 0.45 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.49 |
| Dec 31, 2022 | 0.82 |
| Sep 30, 2022 | 1.48 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.36 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | 0.25 |